Parmax Pharma Ltd - PARMAX PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE240T01014

Parmax Pharma Ltd KEY RATIOS

No Record Found

Parmax Pharma Ltd Corporate Actions

16 Aug , 2023

12:00 AM

AGM

Announcement date: 16 Aug , 2023

View Details

07 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Aug , 2023

12:00 AM

10 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Feb , 2023

12:00 AM

05 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Nov , 2022

12:00 AM

08 Sep , 2022

12:00 AM

AGM

Announcement date: 08 Sep , 2022

View Details

16 Aug , 2023

12:00 AM

BookCloser

View Details

Parmax Pharma Ltd News and Update

Image not found
  • 14 hours ago |
  • 8:36 PM

The deal will be carried out through a wholly-owned subsidiary called Sun Pharma (Netherlands) B.V., the company said, adding that it would "enable Sun Pharma to acquire the balance 25% stake held by the local partner."

Image not found
Image not found
  • IIFL News Service |
  • 27 September, 2023 |
  • 8:33 PM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Parmax Pharma Ltd SHAREHOLDING SNAPSHOT
30 September , 2023 | 01:59 AM

PROMOTER - TOTAL30.80%

Indian: 30.80%

Foreign: 0%

NON-PROMOTER - TOTAL 69.20%

Institutions: 0.00%

Non-Institutions: 69.20%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Parmax Pharma Ltd FINANCIALS

No Data Available To Display Chart

Parmax Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Parmax Pharma Ltd

  • Umang Alkesh Gosalia
  • Managing Director
  • Pramay Amritlal Chhatra
  • Non-Exec. & Independent Dir.
  • Ami R Shah
  • Non-Exec. & Independent Dir.
  • Yash Vora
  • Company Sec. & Compli. Officer
Company FAQ

No Record Found